Literature DB >> 22734086

Silent stroke and cognitive decline in asymptomatic carotid stenosis revascularization.

Laura Capoccia1, Enrico Sbarigia, Annarita Rizzo, Wassim Mansour, Francesco Speziale.   

Abstract

The aim of this study was to assess the relationship between serum levels of S100β and neuron-specific enolase (NSE), postoperative diffusion-weighted magnetic resonance imaging (DW-MRI) and Mini-Mental State Examination (MMSE) score in asymptomatic patients affected by ≥ 70% carotid stenosis submitted to carotid endarterectomy (CEA) or carotid artery stenting (CAS), and to compare MMSE scores and DW-MRI findings at follow-up evaluations. Between April 2008 and April 2009, 60 patients were submitted to carotid intervention. All patients underwent DW-MRI and MMSE preoperatively, at 24 hours postoperatively, at 6 months and at 12 months. Neurobiomarkers were assessed for each patient at six time-points. Thirty-two patients were submitted to CEA and 28 to CAS. No mortality was observed. One CAS patient presented with an ischemic stroke. In six CAS patients and one CEA patient, new subclinical ischemic lesions were detected at postoperative DW-MRI (21.4% versus 3%, P = 0.03). In CAS patients, new DW-MRI lesions were significantly associated with MMSE score decline (P = 0.001). At 12 months, patients presenting with new postoperative ischemic lesions showed lower MMSE scores (P = 0.08). CAS patients showed increasing neurobiomarker levels compared with CEA patients (P = 0.02). In conclusion, microembolization effects may persist over time, so it should be avoided whenever possible. Carotid revascularization procedures should be evaluated and compared not only with respect to death/stroke but also to microembolism rates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734086     DOI: 10.1258/vasc.2011.oa0342

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  8 in total

Review 1.  Carotid revascularization and cognitive impairment: the neglected role of cerebral small vessel disease.

Authors:  Francesco Arba; Federica Vit; Mascia Nesi; Chiara Rinaldi; Mauro Silvestrini; Domenico Inzitari
Journal:  Neurol Sci       Date:  2021-10-01       Impact factor: 3.830

2.  Beneficial effects of intravenous dexmedetomidine on cognitive function and cerebral injury following a carotid endarterectomy.

Authors:  Ya-Li Ge; Xiaobo Li; J U Gao; Xicheng Zhang; Xiangzhi Fang; Luojing Zhou; Wei Ji; Shunyan Lin
Journal:  Exp Ther Med       Date:  2016-01-11       Impact factor: 2.447

3.  [Carotid artery stenting technique].

Authors:  J Schofer; K Bijuklic
Journal:  Herz       Date:  2013-11       Impact factor: 1.443

4.  Does Cognitive Dysfunction after Carotid Endarterectomy Vary by Statin Type or Dose?

Authors:  Eric J Heyer; Joanna L Mergeche; Samuel S Bruce; E Sander Connolly
Journal:  Int J Brain Cogn Sci       Date:  2013

5.  Silent brain infarcts on diffusion-weighted imaging after carotid revascularisation: A surrogate outcome measure for procedural stroke? A systematic review and meta-analysis.

Authors:  Christopher Traenka; Stefan T Engelter; Martin M Brown; Joanna Dobson; Chris Frost; Leo H Bonati
Journal:  Eur Stroke J       Date:  2019-01-15

6.  Effect of carotid artery stenting on cognitive function in patients with carotid artery stenosis: a prospective, 3-month-follow-up study.

Authors:  Byeol A Yoon; Sang Wuk Sohn; Sang Myung Cheon; Dae Hyun Kim; Jae Kwan Cha; Sojeong Yi; Kyung Won Park
Journal:  J Clin Neurol       Date:  2015-04       Impact factor: 3.077

7.  Effects of nurse-led home-based telephone support or home visits on cognitive function.

Authors:  Nanqi Mao; Fangyuan Xue; Wanyu Cai; Jiahong Li
Journal:  Clin Transl Sci       Date:  2021-11-25       Impact factor: 4.689

8.  Risk factors associated with microembolization after carotid intervention.

Authors:  Joseph Sabat; Diane Bock; Chiu-Hsieh Hsu; Tze-Woei Tan; Craig Weinkauf; Theodore Trouard; Gloria Guzman Perez-Carrillo; Wei Zhou
Journal:  J Vasc Surg       Date:  2019-09-05       Impact factor: 4.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.